CARDIOMYOPATHY, SECONDARY
Clinical trials for CARDIOMYOPATHY, SECONDARY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY, SECONDARY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, SECONDARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy targets heart failure in rare genetic disease
Disease control OngoingThis early-stage study tests a one-time gene therapy called LX2006 in 8 people with Friedreich's ataxia who also have heart muscle disease. The therapy delivers a working copy of the frataxin gene directly to heart cells to improve heart function. Researchers will monitor safety …
Matched conditions: CARDIOMYOPATHY, SECONDARY
Phase: PHASE1, PHASE2 • Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated May 26, 2026 10:59 UTC
-
Can a simple risk score stop pacemakers from weakening the heart?
Knowledge-focused OngoingThis study looks at 4,500 people with pacemakers or similar heart devices to find out who is most likely to develop a condition where the heart weakens over time. Researchers will use routine medical and device data to create a risk score that helps doctors choose the best pacing…
Matched conditions: CARDIOMYOPATHY, SECONDARY
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated May 20, 2026 11:58 UTC